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Introduction: The nature of nocturnal cough is largely unknown. It might be a valid marker 
for asthma control but very few studies characterized it as a basis for better defining its role 
and its use as clinical marker. This study investigated prevalence and characteristics of 
nocturnal cough in asthmatics over the course of four weeks.
Methods: In two centers, 94 adult patients with physician-diagnosed asthma were recruited. 
Patient-reported outcomes and nocturnal sensor data were collected by a smartphone with 
a chat-based study app.
Results: Patients coughed in 53% of 2212 nights (range: 0–345 coughs/night). Median 
coughs per hour were 0 (IQR 0–1). Nocturnal cough rates showed considerable inter- 
individual variance. The highest counts were measured in the first 30 min in bed (4.5-fold 
higher than rest of night). Eighty-six percent of coughs were part of a cough cluster. Clusters 
consisted of a median of two coughs (IQR 2–4). Nocturnal cough was persistent within 
patient.
Conclusion: To the best of the authors’ knowledge, this study is the first to describe 
prevalence and characteristics of nocturnal cough in asthma over a period of one month, 
demonstrating that it was a prevalent symptom with large variance between patients and high 
persistence within patients. Cough events in asthmatics were 4.5 times more frequent within 
the first 30 min in bed indicating a potential role of positional change, and not more frequent 
during the early morning hours. An important next step will investigate the association 
between nocturnal cough and asthma control.
Keywords: asthma, nocturnal cough, passive monitoring
Introduction
Asthma is a highly prevalent, heterogeneous, chronic respiratory disease, character-
ized by chronic airway inflammation and a variable expiratory airflow limitation. 
Key symptoms are wheezing, shortness of breath, chest tightness and cough, which 
typically vary over time and in intensity.1
Cough is commonly perceived as a troublesome symptom2 and is associated 
with asthma severity3 and a worse prognosis.4 In asthma, symptoms tend to worsen 
at night and often cause awakenings impacting on quality-of-life.1
The role of nocturnal cough is not well-defined. Due to practical reasons, 
current measures for asthma control do not objectively capture nocturnal cough 
as a parameter of asthma control and potential treatment target. Marsden et al found 
that the rate of nocturnal cough might be a valid marker for asthma control.5 Due to 
the cross-sectional design, however, information regarding longitudinal trends and 
cause–effect relationships of nocturnal cough in asthma is lacking. In a recent study, 
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cough in general and even more nocturnal cough improved 
after appropriate treatment,6 indicating the potential to 
serve as a useful parameter for disease self-monitoring.
The aim of this study was to investigate the prevalence 
and characteristics of nocturnal cough in asthmatic indivi-
duals over the course of four weeks by means of 
a smartphone.
Methods
A detailed study protocol of this two-center, longitudinal, 
observational study has been published before.7 The study 
has been reviewed and approved by the ethics committee 
responsible for research involving humans in eastern 
Switzerland (“Ethikkommission Ostschweiz”, ID: 
2017–01872). The trial registration number on clinical-
trials.gov is NCT03635710. All patients provided written 
informed consent. The study was conducted in accordance 
with the Declaration of Helsinki. In this work, we report 
results of the first study stage, focused on the description 
of nocturnal cough. The results regarding the interaction of 
nocturnal cough and asthma control (ie, the second study 
stage) will be published in a separate paper.
Study Setting
The study was conducted in two centers in Switzerland 
between February 2018 and June 2019: the Lung Center of 
the Cantonal Hospital of St Gallen and the mediX Group 
Practice Zurich in cooperation with the University of 
Zurich. The study duration per participant was 29 days. 
On the first (d1) and the last (d29) study days, participants 
had an in-person appointment at one center. In between, 
patient-reported outcomes and nocturnal sensor data were 
collected by a smartphone. In total, 94 patients were 
recruited. For the recruitment of study participants multi-
ple recruitment channels, personal or impersonal, were 
employed.7
Eligibility Criteria
Eligible for inclusion were adult patients with physician- 
diagnosed asthma, who could give written informed con-
sent and were capable of operating a smartphone. 
Exclusion criteria were cognitive impairment, severe 
insomnia, shift work and sharing the bedroom with 
a person from the same sex. The latter criteria would 
have made a solely acoustic-based allocation of nocturnal 
coughs to the correct person difficult.
Endpoints
The primary endpoint was nocturnal cough rate, obtained 
through smartphone audio recordings, manually labelled 
by trained human annotators. In concordance with recom-
mendations of the European Respiratory Society, cough 
was defined as a three-phase expulsive motor act charac-
terized by an inspiratory effort, followed by a forced 
expiratory effort against a closed glottis, followed by an 
opening of the glottis and rapid expiratory airflow.8 The 
secondary endpoint was cough severity (measured daily by 
a visual analog scale).9
A detailed sample size calculation, participant timeline, 
tasks, and the study flow chart are described in detail in the 
study protocol.7
Data Collection
Medical assessments on d1 and d29 were performed by 
physicians in the study centers. For the measurements 
between physician appointments, patients were equipped 
with a smartphone (Samsung Galaxy A3 2017, SM- 
A320FL) with an installed chat-based study app named 
“Clara”, which is a study-specific adaptation of 
MobileCoach (www.mobile-coach.eu), an open-source 
platform for ecological momentary assessments and beha-
vioral health interventions.10,11 It recorded the participants’ 
sensor data at night (audio data) and delivered the daily 
questionnaires (see also Figure 1 in the published 
protocol).7 A description of all measurements including 
temporal framing and the measures to promote participant 
adherence were described in detail in the published 
protocol.7 Nocturnal cough was labelled only by means of 
audio data. To quantify the labeling quality, two approaches 
were employed. First, human annotators were instructed to 
tag an acoustic event if they were uncertain whether it was 
a cough. Out of a total of 704,697 acoustic events, 30,260 
were classified unambiguously as coughs. In 0.11% of all 
acoustic events, annotators were uncertain (ie, 767 cases). 
These events were not considered in the analysis. Second, 
interrater reliability was estimated for two of the annotators, 
which together have labelled 90.2% of all nights. The two 
labelers had an intraclass correlation (ICC) of 95.8% (mean 
absolute error: 0.44 c/n) and 85.4% (mean absolute error: 
0.76 c/n) for cough in general and coughs correctly assigned 
to the participant’s sex, respectively. These ICCs can 
be interpreted as excellent and good reliabilities, respec-
tively, and were calculated based on 65 nights using a zero- 
inflated generalized mixed-effects model with a Poisson 
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response distribution. To prepare data for analysis, missing 
values for nocturnal cough were imputed. Different imputa-
tion methods were benchmarked by comparing imputations 
to deleted observations. For nocturnal cough, imputation 
was performed by means of a Kalman smoother (based 
on an auto-regressive moving average model fitted across 
all patients). Imputations with negative values were set to 
zero.
Statistical Analysis
All data transformation and analyses were performed with 
R 3.5.1. Bivariate relationships were estimated using 
Pearson’s product-moment correlation (for two metric vari-
ables) and Spearman’s rho (if one variable was on an ordinal 
scale). Differences between groups were tested for statistical 
significance with pairwise Wilcoxon rank-sum tests. Holm’s 
p-value correction was employed to account for multiple 
Figure 1 (A) Distribution of nocturnal cough data. Each bar represents one patient; (B) Nocturnal cough counts—each bar represents one patient. Error bars indicate one 
standard deviation. One patient has not coughed at all; (C) Distribution of cough events in relation to bedtime over all 28 nights (log-scaled). Each dot represents the mean 
number of coughs of a single patient at a given time after going to bed.
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comparisons. The following R packages were used: “dplyr” 
(version 0.8.0.1) for data transformation, “ggplot2” for plot-
ting (version 3.1.0), “Hmisc” (version 4.2) for estimating the 
autocorrelation function, and “stats” (default R) for signifi-
cance testing.
Data Sharing Statement
It is not intended to share individual participant data.
Results
The baseline characteristics of all 94 included patients are 
summarized in Table 1.
In total, 15 of 94 patients had to be excluded from analysis 
(=dropouts). Dropout reasons were the following: two patients 
withdrew by themselves, three patients were nonadherent to 
the study protocol and in 10 patients we missed audio record-
ings for more than five nights. The reasons for missed audio 
recordings can be technology-related (eg, app crash) or 
patient-related (eg, turned off the smartphone at night).
Descriptive Characteristics of Nocturnal 
Cough
Patients coughed in 53% of 2212 nights. Three percent of 
night recordings were missing (67 nights, Figure 1A). 
Median coughs per night were one (IQR 0–8, range: 
0–345). Nocturnal cough counts per patient showed consid-
erable variance between patients. Furthermore, the standard 
deviations per patient indicate that nocturnal cough was 
a time-variant symptom (Figure 1B). The median number 
of coughs per hour was 0 (IQR 0–1, range: 0–136).
The highest cough counts were measured in the first 
30 min in bed with a rather homogeneous distribution 
afterward (first 30 min: 4751 coughs, rest of night: mean 
1050 coughs/30 min; ratio 4.53, Figure 1C).
The following analyses are based on all nights with at 
least one cough. The term “cough cluster” is defined as 
a series of at least two coughs with a maximum time of 
two seconds in between their expulsive phases. Most 
coughs (85.6%) were not isolated, but part of a cough 
cluster. Clusters consisted of a median of two coughs 
(IQR 2–4; Figure 2 and Table s1 and s2).
To explore the temporal stability of nocturnal cough, 
we estimated the auto-correlation function. We found that 
nocturnal cough was persistent within patient up to all 
28 nights (figure s1).
We did not find significant differences regarding noc-
turnal cough counts depending on seasons.
Table 1 Baseline Characteristics
Demographics and Body 
Composition
Age (years) 45 (30–59)
Male, n (%) 41 (44%)
Female, n (%) 53 (56%)
Height, cm 170 (163–176)
Weight, kg 71 (63–83)
Body mass index, kg/m2 25 (22–28)




For current or former smokers
Years smoked 15 (9–20)
Cigarettes per day 14 (10–20)
Pack years 10 (4–15)
Lung function
FEV1, liters 2.9 (2.3–3.4)
FEV1, % predicted 88 (77–101)












Asthma control test at baseline, points 21 (19–23)
Asthma control at baseline, n (%)
Controlled 66 (70%)
Partially controlled 18 (19%)
Uncontrolled (Incomplete 
measurements)
9 (10%) 1 (1%)




● If yes, number of exacerbations 2 (1–2)
● ED visits due to asthma 11 (13%)
● Hospitalizations due to asthma 4 (4%)
Asthma medication, n (%) Prescribed Used
SAMA 5 (5%) 3 (3%)
SABA 52 (55%) 41 (44%)
ICS 86 (91%) 77 (82%)
(Continued)
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Correlation of Measured Nocturnal 
Cough with Subjective Cough Perception
The subjective cough intensity and the predominant day-
times subjectively affected by coughing at baseline are 
described in Table 2.
In Figure 3A, we demonstrate the correlation between the 
self-reported intensity of cough at the first study day with the 
average cough rate over the study period, which was statisti-
cally significant overall (Spearman’s rank correlation 
rho=0.297375; S=57728; p=0.008), but showed no statistically 
significant differences between the groups with different self- 
reported cough intensities. The correlation between the self- 
reported intensity of cough at the last study day with the 
average cough rate over the study period was highly statisti-
cally significant (Spearman’s rank correlation rho=0.5401344; 
S=37783; p=2.784e-07) and also statistically significant dif-
ferences between groups were apparent, meaning that at the 
end of the study, the self-perceived cough-intensity correlated 
better with objectively measured cough rate (Figure 3B).
There were significant correlations between the mea-
sured cough rate and the subjective cough severity of the 
same night, the preceding day and the following day 
(Tables s3-s5). After 33 min, this correlation exceeds the 
lower 95%CI boundary of the entire-night correlation, 
meaning that at least measuring this time is necessary to 
estimate subjective cough severity.
There was a significant correlation between nocturnal 
cough rate and FEV1 (Table 3), whereas we found no 
correlations between nocturnal cough rate and sex, asthma 
severity at baseline, rhinitis or FeNO.
Discussion
In this longitudinal observational study, we investigated 
the prevalence and characteristics of nocturnal cough in 79 
Table 1 (Continued). 
Demographics and Body 
Composition
LABA 78 (83%) 71 (76%)
LAMA 9 (10%) 8 (9%)
Systemic corticosteroids 1 (1%) 0 (0%)
LTRA 10 (11%) 10 (11%)
Anti-IL5 2 (2%) 2 (2%)
Comorbidities, n (%)
Allergic and/or chronic rhinosinusitis 58 (62%)
Arterial hypertension 14 (15%)
Coronary heart disease 4 (4%)
History of myocardial infarction 2 (2%)
Active cancer 2 (2%)
Diabetes 4 (4%)





Note: Data are expressed as median (interquartile range) unless stated otherwise. 
Abbreviations: FEV1, forced expiratory volume in 1 second; FeNO, fraction of 
nitric oxide in exhaled air; Ppb, parts per billion; GINA, global initiative for asthma; 
SAMA, short-acting muscarinic antagonist; SABA, short-acting beta-agonist; ICS, 
inhaled corticosteroid; LABA, long-acting beta-agonist; LAMA, long-acting muscari-
nic antagonist; LTRA, leukotriene-receptor-antagonist; IgE, immunoglobulin E; IL5, 
interleukin-5; ED, emergency department; GERD, gastroesophageal reflux disease.
Figure 2 Distribution of coughs per cluster.
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asthma patients over the course of four weeks. The study 
population was characterized by rather mild, well- 
controlled asthma. Interestingly, only 3% of participants 
were active smokers in comparison to approximately 25% 
in the general Swiss population.
Nocturnal cough in asthmatics occurred in more than 
half of all nights. There was a substantial variance between 
patients. Nocturnal cough was persistent within patients 
over the whole study period. In the first half hour in bed, 
cough rate was much higher (approximately 4.5-fold) than 
in the rest of the night. Most coughs were not isolated, but 
part of cough clusters. There was a significant correlation 
between objectively measured cough rate and subjective 
cough perception as well as baseline FEV1.
Past studies regarding nocturnal respiratory symp-
toms had different limitations, eg were restricted to 
cross-sectional data,5,12 considered limited data 
sources,13 relied exclusively on survey data14–16 or col-
lected data in artificial settings, eg by using 
polysomnography.17–19 Our study setting with the smart-
phone lying near the bed, like many people do routinely, 
aimed to achieve a low patient disturbance and a high 
external validity. This was further supported by real-life 
eligibility criteria, which made inclusion possible for the 
vast majority of patients, which is often not the case in 
asthma-related trials.20
Hirai et al detected nocturnal cough in children with an 
asthma exacerbation by means of microphone and accel-
erometer and found that nocturnal cough rate was highest 
in severe exacerbations, followed by moderate exacerba-
tions and no exacerbation. Cough counts were significantly 
increased at the beginning and the end of the night.21 The 
former could be observed in our study, too. Other studies 
described reduced cough frequencies during nighttime 
with increase at the time of waking.22,23 One hypothesis 
for the explanation of these findings could be that the 
change of body position from upright to supine or vice 
versa could influence lung physics and act as a trigger for 
asthma activity. Further, a central suppressive effect of 
sleep on cough has been described.22 Gastroesophageal 
reflux disease (GERD), which could be a trigger for 
coughing after changing the body position, seems not to 
have played a role in our cohort, because none of the 
participants suffered from GERD. In a recent trial, 
Radine et al used a microphone-based monitoring system 
to count nightly coughs in healthy subjects and in stable 
patients with cystic fibrosis (CF, n=25) and primary ciliary 
dyskinesia (PCD, n=25) over two consecutive nights. 
Nightly cough was absent in healthy subjects and higher 
in CF than in PCD. Further, cough rate in these conditions 
was associated with disease severity.24 Krönig et al used 
the same monitoring system, again over two consecutive 
nights in patients with chronic obstructive pulmonary dis-
ease (COPD) and detected cough in 42 out of 48 patients 
with a range of 1–326 events per night.25
Post hoc, we did not find significant differences regard-
ing nocturnal cough counts depending on seasons. This 
finding has to be interpreted with caution, because robust-
ness is questionable due to the study design, which was 
not intended to investigate seasonality effects. To answer 
this question properly, future research is necessary.
Marsden et al described a weak to moderate association 
between subjective measures of cough and objective 
cough frequency in asthma.26 In the current study, the 
correlation between objectively measured cough rate and 
subjective cough perception improved when comparing 
first and last study day, indicating that patients trained 
their ability to estimate their cough intensity over the 
study period. The correlation between cough rate and 
FEV1 could be a hint towards a possible correlation with 
asthma control.
To the best of our knowledge, this is the first study, 
which evaluated objectively measured nocturnal cough 
frequencies in adult asthmatic patients longitudinally 
(here for one month). Our findings of relevant nocturnal 
cough frequencies with a huge variance between patients 
(and within patients at different time points) are new and 
in line with the abovementioned results from smaller and 
shorter trials regarding other respiratory diseases like 
Table 2 Cough Perception at Baseline
Subjective Cough Intensity at Baseline n (%)
No cough 7 (7)




Very strong 20 (21)
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COPD, CF, and PCD. Our finding concerning the trends of 
nocturnal cough, eg demonstrating that it was a persistent 
symptom over up to 28 nights has also not been described 
in the literature until now.
With this study, we addressed the largely unknown 
nature of nocturnal cough in asthma by objectively and 
extensively measuring its prevalence and describing its 
different characteristics. For future research, these findings 
have to be put in context with other clinical parameters, eg 
like asthma control and exacerbations to develop concrete 
practical implications. In a related second paper, which is 
currently under review, we focus on the interaction of 
nocturnal cough and asthma control.
Strengths and Limitations
As mentioned before, we aimed to achieve the best possi-
ble external validity and generalizability by using conven-
tional smartphones in the bedrooms of the patients in their 
homes, with an app-based system and by keeping exclu-
sion criteria at a minimum. This approach could result in 
a limitation of internal validity, because the study relies 
considerably on patient-reported outcomes and a purely 
Figure 3 Correlation between the self-reported intensity of cough at first (A) and last (B) study day with the average cough rate over the study period. *: statistically 
significant between groups.
Table 3 Pearson Correlations Between Nocturnal Cough and FEV1% Pred
Transformation of Nocturnal Cough r 95%CI t df p
Count of the preceding night −0.132 −0.343; 0.092 −1.167 77 0.247
Mean of the preceding week −0.223* −0.424; −0.002 −2.011 77 0.048
Mean of the preceding month −0.28* −0.472; −0.062 −2.556 77 0.013
Note: *p<0.05.
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sound-based cough annotation approach. Our measures to 
mitigate these aspects can be found in detail in the pub-
lished protocol.7 This study constituted an invasion of 
patients’ privacy and therefore required participants to be 
open for such an intervention, possibly leading to a self- 
selection bias. However, it seems not plausible to assume 
that patients’ attitudes are associated with clinical aspects 
of their asthma, so validity should not be affected by this. 
Another limitation is due to the fact that asthma symptoms 
vary over time.1 With duration of 29 days, our study does 
not allow for the investigation of long-term within-person 
symptom trends and patterns.
Conclusions
In summary, our study is the first to describe prevalence 
and characteristics of nocturnal cough in asthma over 
a period of one month. Nocturnal cough was a prevalent 
symptom with high variance between patients and high 
persistence within patients. Cough events were 4.5 times 
more frequent within the first 30 min in bed indicating 
a potential role of positional change. Nocturnal cough 
characteristics could serve to generate hypotheses regard-
ing pathophysiological aspects of cough. An important 
next step will investigate the association between noctur-
nal cough and asthma control. Based on the upcoming 
results, future research should aim at developing evidence- 
based automated intervention algorithms for adapting 
asthma treatment.
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